When someone arrives at a hospital due to COVID-19 or just about any other issue, pulse oximeters are the go-to gadget to check how much oxygen is in their blood. Once it’s slipped on a patient’s ...

The global pulse oximeter market is expected to expand at a compound annual growth rate (CAGR) of approximately 7% over the forecast period. Market growth is primarily driven by the rising incidence ...

As the founder and chief executive of Masimo Corp., I co-invented the modern day, measure-through motion and low perfusion pulse oximeter (SET Pulse Oximeter) and have spent my life in pursuit of data ...

By Dr. Liji Thomas, MD A major UK study shows that commonly used home pulse oximeters can overestimate oxygen levels in people with darker skin, increasing the risk of undetected hypoxemia and raising ...

A retrospective analysis of more than 7,000 patients with COVID-19 found that pulse oximeter devices—tools that measure oxygen levels in the blood and that are used in virtually every U.S.

The doctors and nurses didn’t believe Tomisa Starr was having trouble breathing. Two years ago, Starr, 61, of Sacramento, California, was in the hospital for a spike in her blood pressure. She has ...

IRVINE, Calif.-- (BUSINESS WIRE)-- Masimo (NASDAQ:MASI) announced today FDA 510 (k) clearance and full market release of Rad-97™ Pulse CO-Oximeter ®, including configurations with integrated NomoLine™ ...

A new battle is emerging in the fight for health equity, and it’s centered on the humble pulse oximeter. On November 1, 2023, 25 state attorneys general sent a letter to the Food and Drug ...

Throughout the COVID-19 pandemic, calls for increased vigilance when using pulse oximeters to measure blood oxygen levels were common, as research indicated these devices may not be as accurate among ...

The global market for smart pulse oximeters is expanding rapidly, driven by increasing incidences of cardiovascular and respiratory diseases and a growing elderly population opting for home care. Read ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of Eve™, a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97™ Pulse ...

Masimo Corporation MASI recently announced the publication of the results of a prospective study in the Sri Lanka Journal of Child Health, demonstrating the efficacy of using Masimo Signal Extraction ...